Stockreport

Inventiva announces filing of its 2023 Universal Registration Document and 2023 Annual Report on Form 20-F

Inventiva S.A. - American Depository Shares  (IVA) 
PDF Daix (France), Long Island City (New York, United States), April 3, 2024 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical [Read more]